Innovent and Eli Lilly announce final clinical results and biomarker analysis of phase-Ib study of Sintilimab injection plus Bevacizumab biosimilar injection Read more
Biocon Biologics receives EU GMP Certification for multiple Biosimilars manufacturing facilities in Bengaluru Read more